At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TNON Tenon Medical, Inc.
Trading 12-09 12:37:11 EST
1.11
+0.00
0.00%
High1.13Low1.10Vol48.43K
Open1.10D1 Closing1.11Amplitude2.70%
Mkt Cap12.01MTradable Cap11.14MTotal Shares10.82M
T/O53.86KT/O Rate0.48%Tradable Shares10.03M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Tenon Medical Chief Commercial Officer Nathaniel A. Grawey Reports Acquisition of Common Shares
Reuters  ·  11-19
Tenon Medical Chief Commercial Officer Nathaniel A. Grawey Reports Acquisition of Common Shares
Tenon Medical, Inc. Receives Buy Rating from Anthony Vendetti Amid Record Revenue and Strategic Expansion
TIPRANKS  ·  11-15
Tenon Medical, Inc. Receives Buy Rating from Anthony Vendetti Amid Record Revenue and Strategic Expansion
Tenon Medical price target lowered to $2.50 from $2.75 at Alliance Global
TIPRANKS  ·  11-15
Tenon Medical price target lowered to $2.50 from $2.75 at Alliance Global
Tenon Medical Raises $2.85 Million in Unregistered PIPE Share Sale
Reuters  ·  11-14
Tenon Medical Raises $2.85 Million in Unregistered PIPE Share Sale
Tenon Medical Q3 EPS $(0.40) Misses $(0.37) Estimate, Sales $1.173M Beat $1.121M Estimate
Benzinga  ·  11-14
Tenon Medical Q3 EPS $(0.40) Misses $(0.37) Estimate, Sales $1.173M Beat $1.121M Estimate
BRIEF-Tenon Medical Q3 Net Income USD -3.339 Million
Reuters  ·  11-14
BRIEF-Tenon Medical Q3 Net Income USD -3.339 Million
Tenon Medical Q3 Operating Expenses USD 4.165 Million
THOMSON REUTERS  ·  11-14
Tenon Medical Q3 Operating Expenses USD 4.165 Million
Tenon Medical Raises $2.85 Million in PIPE Financing
Reuters  ·  11-11
Tenon Medical Raises $2.85 Million in PIPE Financing
Tenon Medical Inc. to Release Third Quarter 2025 Financial Results
Reuters  ·  11-03
Tenon Medical Inc. to Release Third Quarter 2025 Financial Results
Strategic Acquisitions and Product Innovations Drive Buy Rating for Tenon Medical, Inc.
TIPRANKS  ·  10-23
Strategic Acquisitions and Product Innovations Drive Buy Rating for Tenon Medical, Inc.
Tenon Medical Wins FDA Clearance for SImmetry+ SI Joint Fusion System
Reuters  ·  10-21
Tenon Medical Wins FDA Clearance for SImmetry+ SI Joint Fusion System
Tenon Medical Inc. Issues 866,642 Restricted Stock Units to Directors and Officers
Reuters  ·  10-17
Tenon Medical Inc. Issues 866,642 Restricted Stock Units to Directors and Officers
Tenon Medical Inc. Concluded Annual Meeting of Stockholders Virtually
Reuters  ·  09-24
Tenon Medical Inc. Concluded Annual Meeting of Stockholders Virtually
Tenon Medical Inc. Announces Promising 12-Month Results from Catamaran Mainsail Study, Highlighting Significant Pain Reduction and High Fusion Rates in SI Joint Treatment
Reuters  ·  09-04
Tenon Medical Inc. Announces Promising 12-Month Results from Catamaran Mainsail Study, Highlighting Significant Pain Reduction and High Fusion Rates in SI Joint Treatment
Tenon Medical Inc. Launches Catamaran® SE SI Joint Fusion System to Meet Growing Market Demand
Reuters  ·  08-19
Tenon Medical Inc. Launches Catamaran® SE SI Joint Fusion System to Meet Growing Market Demand
Tenon Medical Inc. Releases Transcript of Second Quarter 2025 Financial Results and Corporate Update Conference Call
Reuters  ·  08-19
Tenon Medical Inc. Releases Transcript of Second Quarter 2025 Financial Results and Corporate Update Conference Call
Tenon Medical Q2 2025 Earnings Call Summary and Q&A Highlights: Strategic Acquisition and Product Launches to Drive Growth
Earnings Call  ·  08-14
Tenon Medical Q2 2025 Earnings Call Summary and Q&A Highlights: Strategic Acquisition and Product Launches to Drive Growth
Tenon Medical Inc. Files Initial Beneficial Ownership Statement, Naming Nathaniel A. Grawey as Chief Commercial Officer
Reuters  ·  08-14
Tenon Medical Inc. Files Initial Beneficial Ownership Statement, Naming Nathaniel A. Grawey as Chief Commercial Officer
Tenon Medical Q2 EPS $(0.36) Beats $(0.47) Estimate, Sales $564.000K Miss $909.500K Estimate
Benzinga  ·  08-14
Tenon Medical Q2 EPS $(0.36) Beats $(0.47) Estimate, Sales $564.000K Miss $909.500K Estimate
BRIEF-Tenon Medical Q2 Net Income USD -2.769 Million
Reuters  ·  08-14
BRIEF-Tenon Medical Q2 Net Income USD -2.769 Million

Introduction

Company Name.
Tenon Medical, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Issue price:
--